Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Lilly Cancer Drug Gets New Indication in Europe

By Pharmaceutical Processing | July 10, 2009

INDIANAPOLIS (AP) — Drugmaker Eli Lilly and Co. said Monday that European regulators have approved its cancer treatment Alimta for a new use against certain types of lung cancer. The European Commission granted the drug approval for maintenance treatment of local or advanced nonsquamous, non-small cell lung cancer, a subset of the most common form of lung cancer. Specifically, the chemotherapy drug was indicated for patients whose disease has not progressed after initial treatment with another type of chemotherapy. Traditionally, patients whose cancer is controlled by chemotherapy are monitored until the disease reappears and are then treated with a second form of chemotherapy. Under the new approval, Alimta will be used continuously after the initial chemotherapy treatment. Eli Lilly launched Alimta in 2004. It generated $1.15 billion in sales last year as Lilly’s sixth-best selling drug. It brought in $335 million in the first quarter this year.

Related Articles Read More >

FDA logo
FDA prevented 317 drug shortages in 2021
Pfizer-BioNTech vaccine vial
Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
FDA logo
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
FDA logo
FDA sends warning letters to CBD and delta-8 THC product vendors

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards